Whether this discrepancy is related to a threshold ANA concentration required for nuclear immunolabelling with our protocol or to the presence of immunoreactivity to different nuclear proteins in SLE and MS remains a subject for future investigation. Here, BTG3 is linked to systemic lupus erythematosus.